Evolent Health Stock

Evolent Health Equity

The The Equity of Evolent Health (EVH) as of Aug 19, 2026 is 415.19 M USD. In the previous year, The Equity was 1.00 B USD — a change of -58.53% (lower).

Equity

415.19 MUSD

YoY

-58.53%

Last updated:

In 2026, Evolent Health's equity was 415.19 M USD, a -58.53% increase from the 1.00 B USD equity in the previous year.

Access this data via the Eulerpool API

Evolent Health Stock analysis

What does Evolent Health do? Evolent Health Inc was founded in 2011 and is a healthcare services company based in Arlington, VA USA. The company was founded by a group of CEOs and executives to revolutionize the healthcare system and reduce healthcare costs in the US. Evolent, a wordplay on "evolution" and "diligent," is committed to improving healthcare services through innovative ideas and technologies. Over the years, Evolent Health's business model has evolved and expanded to meet the needs of a wide range of healthcare organizations and their patients. The company works with healthcare organizations such as hospitals, medical centers, health plans, and physicians to provide effective and affordable healthcare solutions. Evolent Health offers various services tailored to the needs of different healthcare organizations. One of their core competencies is the development and implementation of population health management programs. These programs aim to improve patient health while reducing costs. The company also offers technology platforms that healthcare organizations can use to manage data, improve treatment outcomes, and facilitate communication between doctors and patients. Another important aspect of Evolent Health is the care of Medicare and Medicaid patients. The company works with health plans to provide better healthcare services to these underserved populations. Evolent Health also offers specialized services, such as the treatment of patients with chronic conditions like diabetes or cardiovascular diseases. In recent years, Evolent Health has also expanded its portfolio through acquisitions and partnerships. In 2018, two acquisitions were completed, namely Valence Health and New Century Health. These acquisitions have strengthened Evolent Health's position in the field of population health management programs and specialized services for cancer patients. Another innovative product of Evolent Health is the Virtual Health Center. This program offers virtual consultations and treatments for patients who cannot make in-person visits to doctors due to distance or busy lifestyles. The program utilizes state-of-the-art telemedicine technology to provide patients with high-quality medical care while allowing them to stay comfortably at home. Evolent Health has an impressive track record in improving patient outcomes and reducing healthcare costs. In 2020, the company received the highest rating in the "Population Health Management" category of the Healthcare Informatics 100 Rankings. The company serves nearly 3 million patients in the US and operates in over 30 states. Overall, the company has the potential to change the healthcare system in the US and beyond through its vision, innovation, and commitment to high-quality healthcare services. Evolent's focus on improving healthcare delivery and reducing costs has the potential to be a role model for the entire industry. Evolent Health is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Evolent Health's Equity

Evolent Health's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Evolent Health's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Evolent Health's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Evolent Health's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Evolent Health’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Evolent Health stock

The Equity of Evolent Health is 415.19 M USD in 2026.

The Equity of Evolent Health changed from 1.00 B USD to 415.19 M USD, representing a -58.53% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of The Equity Evolent Health since 2006 – with annual values, charts, and detailed analysis.

The Equity's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Evolent Health historically and in real time.

Access this data via the Eulerpool API

Balance Sheet — Evolent Health

All Key Metrics — Evolent Health